Linde, Praxair Deal Faces Regulatory Setback On Antitrust Demands

The $47 billion merger of Linde AG and Praxair Inc. faces the prospect it could collapse for a second time following demands by U.S. antitrust authorities. Bloomberg Opinion's Brooke Sutherland reports on "Bloomberg Daybreak: Americas."

Id 35422 Hsfdhjl

The $47 billion merger of Linde AG and Praxair Inc. faces the prospect it could collapse for a second time following demands by U.S. antitrust authorities. Bloomberg Opinion's Brooke Sutherland reports on "Bloomberg Daybreak: Americas."

More in Mergers & Acquisitions